Evidence map›Paper›PMID 37965468›Full record

ArticleFrontiers in oncology2023

Invasive fungal infections in pediatric patients with central nervous system tumors: novel insights for prophylactic treatments?

Natália Dassi, Andrea Maria Cappellano, Adriana Maria Paixão de Sousa da Silva, Nasjla Saba da Silva, Fabianne Altruda de Moraes Costa Carlesse

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 1 citations in OpenAlex.

  1. Brazilian guidelines for the diagnosis and treatment of candidemia and invasive candidiasis in adults and children.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Guideline
  2. Article
  3. Urinary tract infection caused by rare yeastFrontiers in immunology · 2026
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Natália Dassi *Pediatric Oncology, Pediatric Oncology Institute-GRAACC (IOP-GRAACC)/Federal University of São Paulo, São Paulo, Brazil.
Andrea Maria Cappellano *Pediatric Oncology, Pediatric Oncology Institute-GRAACC (IOP-GRAACC)/Federal University of São Paulo, São Paulo, Brazil.
Adriana Maria Paixão de Sousa da SilvaPediatric Infectology, IOP-GRAACC/Federal University of São Paulo, São Paulo, Brazil.
Nasjla Saba da SilvaPediatric Oncology, Pediatric Oncology Institute-GRAACC (IOP-GRAACC)/Federal University of São Paulo, São Paulo, Brazil.
Fabianne Altruda de Moraes Costa Carlesse *Pediatric Infectology, IOP-GRAACC/Federal University of São Paulo, São Paulo, Brazil.
Universidade Federal de São Paulo · BRSupport group for adolescents and children with cancer · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and aims: Invasive fungal disease (IFD) poses significant morbidity and mortality risks, especially in pediatric patients with neoplastic diseases. However, there is a notable lack of data concerning patients with central nervous system (CNS) tumors. Considering vulnerability factors to infections such as neutropenia, corticosteroids, chemotherapy, surgical interventions, and others, this study aims to evaluate the incidence of IFD in pediatric patients with CNS tumors and determine appropriate indications for prophylactic measures. This is a single-center, retrospective study conducted between 2011 and 2022 at the Pediatric Institute of Oncology (IOP-GRAACC-UNIFESP). Results: A total of 38 cases of IFD were diagnosed in 818 children with CNS malignancies (4,6%). The mean age was 3.5 years (0.4-28y), with 22 (57.9%) male patients. Embryonal tumors (18/38, 47.3%) were the most prevalent CNS tumors, followed by low-grade gliomas (13/38, 34.2%). All episodes met the EORTC IFD criteria, and 36/38 (94.7%) were proven. Invasive yeast infections (33/36, 91.6%), predominantly Conclusion: Routine systemic antifungal prophylaxis based solely on diagnosis is not recommended for low-risk cases. Evaluating patient- and treatment-specific risk factors is crucial in infants undergoing high-dose chemotherapy with expected neutropenia and in patients requiring prolonged corticosteroid therapy alongside neurosurgical procedures.

Indexed as

infectious diseasesIntracranial tumorsinvasive fungal infectionspediatric central nervous system tumorsprophylactic treatments

Identifiers

PMID37965468
PMCPMC10641464
OpenAlexW4387968476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.